-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Repare Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
- Repare Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $485K.
- Repare Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.63M, a 70.1% decline year-over-year.
- Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was -$9.38M, a 162% decline from 2022.
- Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $15.1M.
- Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.68M, a 26.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)